What are decentralized clinical trials and why are they here to stay
Join us at this Live Panel Discussion organized by Barcelona Health Hub, where industry leaders will share their insights and experiences with decentralized trials and the leverage of digital solutions that are allowing to adopt a patient-centric focus when creating and running clinical trials.
What are decentralized clinical trials?
What does the decentralized trials global landscape look like?
What is a Direct to Patient (DtP) trial?
How has COVID been an inflection point for DtP trials?
How have trial designs shifted and supply chain strategies changed to accommodate for an increased need for flexibility and decentralization?
What are some of the barriers clinical trials stakeholders are experiencing to implement these kinds of trials? Any difference between regions?
Are decentralized trials the future of clinical trials designs going forward?